These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1971967)

  • 1. Common biochemical pathway of dysmorphogenesis in murine embryos: use of the glucocorticoid pathway by phenytoin.
    Kay ED; Goldman AS; Daniel JC
    Teratog Carcinog Mutagen; 1990; 10(1):31-9. PubMed ID: 1971967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid reversal of phenytoin-induced neural tube and craniofacial defects in vitro in mice.
    Kay ED; Goldman AS; Daniel JC
    J Craniofac Genet Dev Biol; 1988; 8(2):179-86. PubMed ID: 3141453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palatal development and the arachidonic acid cascade.
    Piddington RL; Goldman AS
    Prog Clin Biol Res; 1985; 171():295-306. PubMed ID: 3885248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical mechanism of glucocorticoid-and phenytoin-induced cleft palate.
    Goldman AS
    Curr Top Dev Biol; 1984; 19():217-39. PubMed ID: 6389029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The arachidonic acid cascade is involved in the masculinizing action of testosterone on embryonic external genitalia in mice.
    Gupta C; Goldman AS
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4346-9. PubMed ID: 3086881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2 histocompatibility region influences the inhibition of arachidonic acid cascade by dexamethasone and phenytoin in mouse embryonic palates.
    Gupta C; Katsumata M; Goldman AS
    J Craniofac Genet Dev Biol; 1985; 5(3):277-85. PubMed ID: 4044790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor IB: mediator of anti-inflammatory and teratogenic functions of both glucocorticoids and phenytoin.
    Katsumata M; Gupta C; Goldman AS
    Arch Biochem Biophys; 1985 Dec; 243(2):385-95. PubMed ID: 2867743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
    Wentzel P; Eriksson UJ
    Diabetes; 1998 Apr; 47(4):677-84. PubMed ID: 9568703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced alterations in craniofacial gene expression.
    Gelineau-van Waes J; Bennett GD; Finnell RH
    Teratology; 1999 Jan; 59(1):23-34. PubMed ID: 9988880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2 influences phenytoin binding and inhibition of prostaglandin synthesis.
    Gupta C; Katsumata M; Goldman AS
    Immunogenetics; 1984; 20(6):667-76. PubMed ID: 6439630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in spontaneous and diphenylhydantoin-induced craniofacial malformations in mice.
    Brown KS; Evans MI; Harne LC
    J Craniofac Genet Dev Biol Suppl; 1985; 1():305-12. PubMed ID: 3877104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogenicity screening in standardized chick embryo culture: effects of dexamethasone and diphenylhydantoin.
    Kucera P; Burnand MB
    Experientia; 1988 Oct; 44(10):827-33. PubMed ID: 3181369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    Winn LM; Wells PG
    Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
    Ozolins TR; Wiley MJ; Wells PG
    Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
    Winn LM; Wells PG
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for a role of arachidonic acid in glucocorticoid teratogenic action in the palate.
    Piddington R; Herold R; Goldman AS
    Proc Soc Exp Biol Med; 1983 Dec; 174(3):336-42. PubMed ID: 6420792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture model.
    Shanks MJ; Wiley MJ; Kubow S; Wells PG
    Teratology; 1989 Oct; 40(4):311-20. PubMed ID: 2814893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.